{"id":"https://openalex.org/W2734485602","doi":null,"title":"A comprehensive analysis of development attrition in drug candidates from four major pharmaceutical companies","display_name":"A comprehensive analysis of development attrition in drug candidates from four major pharmaceutical companies","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2734485602","mag":"2734485602"},"language":"en","primary_location":{"id":"mag:2734485602","doi":null,"is_oa":false,"landing_page_url":"http://oak.novartis.com/22853/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2734485602"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049853983","display_name":"Owen B. Wallace","orcid":"https://orcid.org/0000-0001-8162-8593","observed_orcids":["https://orcid.org/0000-0001-8162-8593"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Owen B. Wallace","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109939857","display_name":"John E. Arrowsmith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Arrowsmith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036729806","display_name":"Andrew R. Leach","orcid":"https://orcid.org/0000-0001-8178-0253","observed_orcids":["https://orcid.org/0000-0001-8178-0253"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew R. Leach","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8178-0253","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037689001","display_name":"Paul D. Leeson","orcid":"https://orcid.org/0000-0003-0212-3437","observed_orcids":["https://orcid.org/0000-0003-0212-3437"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul D. Leeson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0212-3437","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006029703","display_name":"Sam Mandrell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sam Mandrell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Robert M. Owen","orcid":"https://orcid.org/0000-0002-3359-8614","observed_orcids":["https://orcid.org/0000-0002-3359-8614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert M. Owen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3359-8614","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091180633","display_name":"Garry Pairaudeau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Garry Pairaudeau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112508806","display_name":"William D. Pennie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William D. Pennie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079075074","display_name":"Stephen D. Pickett","orcid":"https://orcid.org/0000-0002-0958-9830","observed_orcids":["https://orcid.org/0000-0002-0958-9830"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen D. Pickett","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0958-9830","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049852138","display_name":"Ji\u2010Bo Wang","orcid":"https://orcid.org/0000-0003-2271-6459","observed_orcids":["https://orcid.org/0000-0003-2271-6459"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ji\u2010Bo Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2271-6459","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Michael J. Waring","orcid":"https://orcid.org/0000-0002-9110-8783","observed_orcids":["https://orcid.org/0000-0002-9110-8783"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J. Waring","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9110-8783","affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Alex. M. Weir","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex. M. Weir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.7562999725341797,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.7562999725341797,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0674000009894371,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.06239999830722809,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-attrition","display_name":"drug attrition","score":0.8899999856948853},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.5389999747276306},{"id":"https://openalex.org/keywords/oral-drug-candidates","display_name":"oral drug candidates","score":0.8379999995231628},{"id":"https://openalex.org/keywords/toxicology","display_name":"toxicology","score":0.7960000038146973},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C2780553607","wikidata":"https://www.wikidata.org/wiki/Q684868","display_name":"Attrition","level":2,"score":0.7890821695327759},{"id":"https://openalex.org/C70437156","wikidata":"https://www.wikidata.org/wiki/Q7228652","display_name":"Pooling","level":2,"score":0.6903579235076904},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.5141223073005676},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.43876007199287415},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3987605571746826},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3684050440788269},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.3321053981781006},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.330960750579834},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.32545626163482666},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2567893862724304},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24569305777549744},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.09282907843589783},{"id":"https://openalex.org/C199343813","wikidata":"https://www.wikidata.org/wiki/Q12128","display_name":"Dentistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2734485602","doi":null,"is_oa":false,"landing_page_url":"http://oak.novartis.com/22853/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1663154925","https://openalex.org/W2127451270","https://openalex.org/W7062448060","https://openalex.org/W4254308596","https://openalex.org/W4245888102","https://openalex.org/W103689249","https://openalex.org/W2336612894","https://openalex.org/W1608404542","https://openalex.org/W2137685870","https://openalex.org/W1977212874"],"abstract_inverted_index":{"A":[0],"compilation":[1],"of":[2,44,59,66,73,76,97],"attrition":[3],"data":[4,37],"for":[5],"oral":[6],"development":[7],"compounds":[8],"nominated":[9],"by":[10],"four":[11],"large":[12],"pharmaceutical":[13],"companies":[14],"(AstraZeneca,":[15],"Eli":[16],"Lilly,":[17],"GlaxoSmithkline":[18],"and":[19,50,70,83,93],"Pfizer)":[20],"in":[21],"the":[22,52,57,64,74,94,98],"period":[23],"2000":[24],"to":[25,40],"2010":[26],"has":[27],"been":[28],"carried":[29],"out.":[30],"It":[32],"was":[33],"anticipated":[34],"that":[35,51],"pooling":[36],"would":[38,55],"help":[39],"minimize":[41],"any":[42],"issues":[43],"inter-company":[45],"variability":[46],"as":[47],"described":[48],"above":[49],"larger":[53],"dataset":[54,69],"increase":[56],"chances":[58],"observing":[60],"meaningful":[61],"relationships.":[62],"Here,":[63],"nature":[65],"this":[67],"compiled":[68],"an":[71],"analysis":[72],"causes":[75],"attrition,":[77],"with":[78],"a":[79],"focus":[80],"on":[81],"toxicology":[82],"safety,":[84],"are":[85,101],"described.":[86],"The":[88],"links":[89],"between":[90],"these":[91],"observations":[92],"physical":[95],"properties":[96],"drug":[99],"candidates":[100],"assessed":[102]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2734485602","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2017-07-21T00:00:00"}
